Pain Management
Tonix Pharmaceuticals Secures GPO Agreement Covering 35 Million Lives for TONMYA Fibromyalgia Treatment
Tonix Pharmaceuticals announced a group purchasing organization agreement effective May 1, 2026, covering approximately 35 million U.S. commercial lives for its FDA-approved non-opioid fibromyalgia treatment TONMYA, expanding patient access.
Aclarion Appoints Daniel Keefe as Commercial Director to Drive Western U.S. Expansion of Nociscan
Aclarion hires Daniel Keefe to lead Western U.S. commercial efforts, capitalizing on triple-digit growth in Nociscan utilization for chronic low back pain diagnosis.
BioElectronics Expands ActiPatch to Taiwan Through Aphrodite Medical Group Partnership
BioElectronics Corporation's expansion of its FDA-cleared ActiPatch device to Taiwan through distributor Aphrodite Medical Group represents a significant shift toward drug-free pain management alternatives in Asian healthcare markets.
Aclarion Secures U.S. Patent for AI-Driven Chronic Back Pain Assessment Technology
Aclarion has obtained a U.S. patent for its AI-powered platform that analyzes spinal data to identify sources of chronic low back pain, potentially improving surgical outcomes and expanding access to more consistent diagnostics.
Minnesota Patient Achieves Chronic Pain Recovery Through Non-Surgical Treatment Approach
A Woodbury resident overcame five years of chronic neck pain and mobility issues through ALIGN Integrated Health's comprehensive non-surgical treatment program, demonstrating an effective alternative to invasive procedures.
Medical Cannabis Access Linked to Reduced Opioid Use Among Cancer Surgery Patients
A new study reveals that states with medical cannabis dispensaries show decreased opioid prescriptions for cancer surgery patients but increased non-treatment hospital visits, highlighting the complex implications of cannabis policy on pain management and healthcare utilization.
Nutriband Founder Returns as CEO to Lead Final Development of Abuse-Deterrent Fentanyl Patch
Nutriband founder Gareth Sheridan has resumed his role as CEO to lead the final development phase of AVERSA Fentanyl, an abuse-deterrent opioid patch with potential peak annual U.S. sales estimated between $80 million and $200 million.
Stanford Study Shows Pulsed Shortwave Therapy Provides Sustained Pain Relief for Thumb Arthritis
A Stanford University clinical trial demonstrates that pulsed shortwave therapy offers lasting pain relief for thumb arthritis, potentially providing a safe, drug-free alternative to current limited treatment options for millions of affected adults.
National Survey Reveals Nearly Half of US Adults Experience Unexplained or Treatment-Resistant Pain and Illness
A groundbreaking national survey to be presented at the Association for the Treatment of Neuroplastic Symptoms conference shows that 40% of Americans seeking medical care have symptoms likely caused by stress-induced neural pathway changes rather than structural issues.
Holistix Introduces Red Light Therapy Slippers for At-Home Foot Pain Relief
Holistix International's new SKO Red Light Therapy Slippers offer a convenient, science-backed alternative to traditional foot pain treatments, potentially transforming how millions manage chronic foot conditions at home.
Cayenne Wellness Center Hosts 17th Annual Sickle Cell Summit Focusing on Pain Management and Physician Perspectives
The 17th Annual Sickle Cell Disease Educational Summit addresses critical gaps in pain management and healthcare provider education through innovative sessions featuring physicians who live with the condition, aiming to transform clinical approaches and patient care standards.
New Podcast Explores Neuroplastic Pain Affecting 1.5 Billion People Worldwide
Dr. David Clarke's podcast 'The Story Behind the Symptoms' addresses the growing epidemic of neuroplastic pain conditions through patient interviews and evidence-based Neuroplastic Recovery Therapy, offering alternatives to traditional medical treatments.
Integrated Pain Associates Expands Reach in Texas Through Partnership with Lubbock Spine Institute
Integrated Pain Associates partners with Lubbock Spine Institute to enhance access to minimally invasive pain management services in West Texas, marking a significant step in addressing unmet healthcare needs in underserved areas.
Innovative Small-Cap Biopharma Companies Lead the Future of Pain Therapy
The transdermal patch market, especially for pain therapy, is experiencing significant growth, offering safer alternatives to traditional opioid use and attracting investor interest in small-cap biopharma companies.
Tonix Pharmaceuticals to Showcase Innovations at 2025 BIO International Convention
Tonix Pharmaceuticals Holding Corp. is set to present at the 2025 BIO International Convention, highlighting its advancements in pain management and public health solutions, including a potential new treatment for fibromyalgia.
Nutriband Inc. Advances Abuse-Deterrent Buprenorphine Therapy with AVERSA Technology
Nutriband Inc. is pioneering a novel transdermal delivery system for buprenorphine, aiming to address the opioid epidemic with safer treatment options, potentially revolutionizing pain and addiction therapies.
Nutriband Seeks to Revolutionize Transdermal Pain Management Through Innovative Abuse-Deterrent Technology
Nutriband is developing a groundbreaking transdermal drug delivery platform aimed at addressing pain management challenges in the wake of the opioid crisis, focusing on creating safer, more accessible opioid therapies.
Miami Surgeon Pioneers Zero-Pain Aesthetic Procedures with Innovative Technique
Dr. Rian Maercks of The Maercks Institute introduces a revolutionary surgical approach using Exparel, enabling aesthetic procedures with minimal pain, no opioids, and rapid recovery, potentially transforming patient experiences in plastic surgery.
Nutriband Advances Opioid Patch Technology with Potential Abuse-Deterrent Solution
Nutriband is making significant progress toward commercializing its AVERSA Fentanyl technology, partnering with Kindeva Drug Delivery to develop a potentially groundbreaking opioid pain patch with abuse-deterrent properties.
Nutriband Develops Innovative Abuse-Deterrent Fentanyl Patch to Address Opioid Crisis
Nutriband Inc. has developed AVERSA™ Fentanyl, a technologically advanced transdermal patch designed to provide effective pain management while mitigating potential opioid abuse risks. The innovation represents a strategic approach to addressing the ongoing public health challenge of the opioid epidemic.
Highland Park Dentist Offers Revolutionary Self-Administered Pain Relief Technique for Migraines and Headaches
Dr. Ira Shapira teaches patients and medical professionals a self-administered technique for Sphenopalatine Ganglion (SPG) Blocks, offering rapid pain relief for migraines, cluster headaches, and other autonomic cephalgias using a minimally invasive method.
Nutriband Advances Abuse-Deterrent Fentanyl Patch in Response to Opioid Crisis
Nutriband is developing an innovative abuse-deterrent transdermal fentanyl patch amid shifting FDA regulations and ongoing efforts to combat opioid misuse. The technology represents a potential breakthrough in safer pain management strategies.